Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Cirrhosis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    September 2022
  1. SINGH A, De A, Singh MP, Rathi S, et al
    Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
    Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
    PubMed     Abstract available


  2. CHAPIN SE, Goldberg DS, Kaplan DE, Mahmud N, et al
    External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.
    Dig Dis Sci. 2022;67:4581-4589.
    PubMed     Abstract available


    August 2022
  3. AMES PRJ, D'Andrea G, Arcaro A, Marottoli V, et al
    Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
    Dig Dis Sci. 2022 Aug 24. pii: 10.1007/s10620-022-07666.
    PubMed     Abstract available


  4. PREMKUMAR M, Mehtani R, Kulkarni AV, Duseja AK, et al
    Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding.
    Dig Dis Sci. 2022 Aug 19. pii: 10.1007/s10620-022-07656.
    PubMed     Abstract available


  5. FERREIRA RD, John BV
    Viral Vector Vaccines Are Victorious Against COVID-19 in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Aug 10. pii: 10.1007/s10620-022-07644.
    PubMed    


    July 2022
  6. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    PubMed    


  7. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    PubMed     Abstract available


  8. ELFEKI MA, Robles J, Akhtar Z, Ullah F, et al
    Impact of Fibrosis-4 Index Prior to COVID-19 on Outcomes in Patients at Risk of Non-alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2022;67:3333-3339.
    PubMed     Abstract available


    June 2022
  9. VIJAYARAGHAVAN R, Sarin SK, Bharadwaj A, Anand L, et al
    Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months.
    Dig Dis Sci. 2022 Jun 28. pii: 10.1007/s10620-022-07596.
    PubMed     Abstract available


  10. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    PubMed     Abstract available


  11. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    PubMed     Abstract available


    May 2022
  12. ASOTIBE JC, Banini BA
    Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07523.
    PubMed    


  13. OSMAN KT, Abdelfattah AM, Mahmood SK, Elkhabiry L, et al
    Refractory Hepatic Hydrothorax Is an Independent Predictor of Mortality When Compared to Refractory Ascites.
    Dig Dis Sci. 2022 May 9. pii: 10.1007/s10620-022-07522.
    PubMed     Abstract available


    April 2022
  14. B HADI Y, Khan RS, Lakhani DA, Khan AY, et al
    Antibiotic Prophylaxis for Upper Gastrointestinal Bleed in Liver Cirrhosis; Less May Be More.
    Dig Dis Sci. 2022 Apr 25. pii: 10.1007/s10620-022-07481.
    PubMed     Abstract available


  15. NOUREDDIN N, Noureddin M, Singh A, Alkhouri N, et al
    Progression of Nonalcoholic Fatty Liver Disease-Associated Fibrosis in a Large Cohort of Patients with Type 2 Diabetes.
    Dig Dis Sci. 2022;67:1379-1388.
    PubMed     Abstract available


    March 2022
  16. BUCSICS T, Lampichler K, Vierziger C, Schoder M, et al
    Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
    Dig Dis Sci. 2022 Mar 17. pii: 10.1007/s10620-022-07443.
    PubMed     Abstract available


  17. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
    PubMed    


    February 2022
  18. SINGH AD, Ford A, Lyu R, Layoun H, et al
    Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study.
    Dig Dis Sci. 2022 Feb 12. pii: 10.1007/s10620-022-07412.
    PubMed     Abstract available


  19. ROGAL SS, Chinman MJ, DeMonte W, Gibson S, et al
    Using Intervention Mapping to Develop a Novel Pain Self-Management Intervention for People with Cirrhosis.
    Dig Dis Sci. 2022 Feb 11. pii: 10.1007/s10620-022-07380.
    PubMed     Abstract available


  20. SHENOY A, Louissaint J, Shannon C, Tapper EB, et al
    Viscoelastic Testing Prior to Non-surgical Procedures Reduces Blood Product Use Without Increasing Bleeding Risk in Cirrhosis.
    Dig Dis Sci. 2022 Feb 5. pii: 10.1007/s10620-021-07376.
    PubMed     Abstract available


  21. GIBBS JT, Louissaint J, Tapper EB
    Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma.
    Dig Dis Sci. 2022 Feb 2. pii: 10.1007/s10620-022-07400.
    PubMed     Abstract available


    January 2022
  22. GONZALEZ JJ, Dziwis J, Patel YA, Tapper EB, et al
    Identifying Ascites in Patients with Cirrhosis Using Administrative Codes and Diuretic Use: A Multicenter Study.
    Dig Dis Sci. 2022 Jan 28. pii: 10.1007/s10620-021-07367.
    PubMed     Abstract available


  23. PANCHAL SA, Kaplan DE, Goldberg DS, Mahmud N, et al
    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis.
    Dig Dis Sci. 2022 Jan 13. pii: 10.1007/s10620-021-07321.
    PubMed     Abstract available


  24. CHANDAN S, Deliwala S, Khan SR, Ramai D, et al
    Advanced Endoscopic Resection Techniques in Cirrhosis-A Systematic Review and Meta-Analysis of Outcomes.
    Dig Dis Sci. 2022 Jan 6. pii: 10.1007/s10620-021-07364.
    PubMed     Abstract available


  25. KHALIFA A, Sasso R, Rockey DC
    Role of Liver Biopsy in Assessment of Radiologically Identified Liver Masses.
    Dig Dis Sci. 2022;67:337-343.
    PubMed     Abstract available


    December 2021
  26. HIGUERA-DE-LA-TIJERA F, Cordova-Gallardo J, Buganza-Torio E, Barranco-Fragoso B, et al
    Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value.
    Dig Dis Sci. 2021;66:4501-4507.
    PubMed     Abstract available


    November 2021
  27. DONG TS, Jacobs JP, Agopian V, Pisegna JR, et al
    Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2021 Nov 20. pii: 10.1007/s10620-021-07299.
    PubMed     Abstract available


  28. PODRUG K, Trkulja V, Zelenika M, Bokun T, et al
    Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07277.
    PubMed     Abstract available


  29. BENITEZ C
    Pressure Measurements Under Pressure: Simplifying the Diagnosis of Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Nov 5. pii: 10.1007/s10620-021-07283.
    PubMed    


  30. ABDU B, Akolkar S, Picking C, Boura J, et al
    Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2021;66:4035-4045.
    PubMed     Abstract available


    October 2021
  31. BURKHOLDER DA, Moran IJ, DiBattista JV, Lok AS, et al
    Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications.
    Dig Dis Sci. 2021 Oct 21. pii: 10.1007/s10620-021-07282.
    PubMed     Abstract available


    September 2021
  32. LI J, Lu M, Zhou Y, Bowlus CL, et al
    Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2021 Sep 9. pii: 10.1007/s10620-021-07219.
    PubMed     Abstract available


  33. CHUN HS, Lee JS, Lee HW, Kim BK, et al
    Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B.
    Dig Dis Sci. 2021 Sep 2. pii: 10.1007/s10620-021-07157.
    PubMed     Abstract available


  34. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    


    August 2021
  35. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    PubMed     Abstract available


  36. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
    PubMed     Abstract available


  37. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    PubMed     Abstract available


  38. ZHANG S, Tao X, Wang L, Chen H, et al
    Downregulation of Programmed Death-1 Pathway Promoting CD8 + T Cell Cytotoxicity in Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07165.
    PubMed     Abstract available


  39. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
    PubMed    


  40. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    PubMed     Abstract available


    July 2021
  41. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed     Abstract available


  42. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    PubMed     Abstract available


  43. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.
    PubMed    


    June 2021
  44. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    PubMed     Abstract available


  45. CANCADO GGL, Braga MH, Ferraz MLG, Villela-Nogueira CA, et al
    Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07122.
    PubMed     Abstract available


  46. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    PubMed     Abstract available


  47. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    PubMed     Abstract available


  48. GELOW K, Chalasani S, Green K, Lammert C, et al
    Utilization and Impact of Complementary and Alternative Medicines in Symptomatic Autoimmune Hepatitis Patients.
    Dig Dis Sci. 2021 Jun 23. pii: 10.1007/s10620-021-07112.
    PubMed     Abstract available


  49. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed     Abstract available


  50. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    PubMed     Abstract available


    May 2021
  51. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    PubMed     Abstract available


  52. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    PubMed     Abstract available


  53. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    PubMed     Abstract available


  54. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    PubMed    


  55. LIN MH, Li HQ, Zhu L, Su HY, et al
    Liver Fibrosis in the Natural Course of Chronic Hepatitis B Viral Infection: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07009.
    PubMed     Abstract available


  56. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    PubMed     Abstract available


    April 2021
  57. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    PubMed     Abstract available


    March 2021
  58. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    PubMed     Abstract available


    February 2021
  59. JONES BE, Allegretti AS, Pose E, Mara KC, et al
    Renal Replacement Therapy for Acute Kidney Injury in Severe Alcohol-Associated Hepatitis as a Bridge to Transplant or Recovery.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06864.
    PubMed     Abstract available


  60. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    PubMed     Abstract available


    January 2021
  61. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    PubMed     Abstract available


  62. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    PubMed     Abstract available


    November 2020
  63. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    PubMed     Abstract available


  64. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    PubMed     Abstract available


  65. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    PubMed     Abstract available


  66. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    PubMed     Abstract available


    October 2020
  67. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    PubMed     Abstract available


    September 2020
  68. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
    Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
    Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
    PubMed     Abstract available


  69. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  70. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    PubMed     Abstract available


    August 2020
  71. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    PubMed     Abstract available


  72. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    PubMed     Abstract available


  73. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
    PubMed    


  74. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    PubMed     Abstract available


  75. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    PubMed     Abstract available


  76. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    PubMed     Abstract available


  77. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    PubMed     Abstract available


    July 2020
  78. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    PubMed     Abstract available


  79. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    PubMed     Abstract available


    June 2020
  80. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    PubMed     Abstract available


    May 2020
  81. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    PubMed    


    April 2020
  82. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    PubMed     Abstract available


  83. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
    PubMed    


  84. O'BEIRNE J
    Liver Transplantation for Alcoholic Liver Disease: Absence of Evidence for the Relevance of Abstinence.
    Dig Dis Sci. 2020 Apr 3. pii: 10.1007/s10620-020-06235.
    PubMed    


    March 2020
  85. LI J, Dong S, Ye M, Peng G, et al
    MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
    PubMed     Abstract available


    February 2020
  86. MELLINGER JL, Stine JG
    Early Liver Transplantation for Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2020 Feb 27. pii: 10.1007/s10620-020-06159.
    PubMed     Abstract available


  87. AMJAD W, Alukal J, Doycheva I, Zhang T, et al
    A Combination of N-Acetylcysteine and Prednisone Has No Benefit Over Prednisone Alone in Severe Alcoholic Hepatitis: A Retrospective Analysis.
    Dig Dis Sci. 2020 Feb 18. pii: 10.1007/s10620-020-06142.
    PubMed     Abstract available


    January 2020
  88. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
    Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
    Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
    PubMed     Abstract available


  89. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    PubMed    


    December 2019
  90. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
    Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
    PubMed     Abstract available


  91. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    PubMed     Abstract available


    November 2019
  92. CHEN Y, Ji H, Shao J, Jia Y, et al
    Different Hepatitis C Virus Infection Statuses Show a Significant Risk of Developing Type 2 Diabetes Mellitus: A Network Meta-Analysis.
    Dig Dis Sci. 2019 Nov 23. pii: 10.1007/s10620-019-05918.
    PubMed     Abstract available


  93. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    PubMed     Abstract available


    October 2019
  94. HUANG R, Rao H, Yang M, Gao Y, et al
    Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05886.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: